Preclinical studies are an important part of biomedical research, often guiding future trials in humans. Failure to replicate research results suggests a need to increase the quality of studies.
Major study shows the need to improve how scientists approach early-stage cancer research
Robert Nadon, Associate Professor, Department of Human Genetics, Faculty of Medicine, McGill University